High LBX2-AS1 expression levels were detected in clinical tissue samples and cancer cell lines in studies focused on non-small cell lung cancer (NSCLC), esophageal squamous cell carcinoma (ESCC), and multiple myeloma (MM) [28, 53, 54]. The gene discussed is LBX2; the disease is Miyoshi myopathy.